ALL
Pharma?in?China
Pharma?Experts
Market News
Products Guide
Brand Story
-
SpyBiotech Licenses Selexis’ SUREtechnology for HCMV Vax contractpharma
March 19, 2021Selexis SA, a JSR Life Sciences company, and SpyBiotech, a biotechnology company with a novel vaccine platform, have signed a commercial license agreement to advance SPYVLP102, SpyBiotech’s lead vaccine program for human cytomegalovirus (HCMV).
Pharma Sources Insight January 2025
